The New Mastermind Search Interface – Now with Phenotypes

We have made updates to the Mastermind Genomic Search Engine interface to streamline the user experience and prepare the way for some exciting new developments – the first of which is the ability to search by Human Phenotype Ontology (HPO) terms!

Read more

Genomenon Research Report: Fusion Genes of Clinical Significance in 2019

Fusion genes have long been known to play an important role in the development of cancer. Identifying and documenting each newly discovered fusion is crucial in both patient diagnosis and the development of Precision Medicine. The Genomenon team used the Mastermind Genomic Search Engine to compile a comprehensive knowledgebase of literature regarding gene fusions in …

Read more

AI-Driven Literature Curation for Determining Genomic Variant Pathogenicity

Mark Kiel, Founder and Chief Science Officer of Genomenon was a featured presenter for the LabRoots Virtual Genetics & Genomics Event on May 8th and 9th, 2019. This is the transcript, slides and video from his talk, which opened the event on Thursday, May 9th.

Read more

Don’t Call It a Comeback

Mark Kiel, Founder and Chief Science Officer of Genomenon, shares his comeback story at Startup Story Night 2019 at the Marble Bar in Detroit. Genomenon has come a very long way. Like any good story, we had our ups and downs, moments of excitement and fear while rapidly growing in a developing industry. Read about …

Read more

Genomenon Research Report: Emerging Genomic Variants in 2018

2018 has been another banner year in the progression of Precision Medicine! Year over year, there has been a dramatic rise in the number of scientific studies and initiatives that resulted in meaningful published findings, and 2018 was another record-breaker. To demonstrate trends in genetics and genomics research seen through the lens of scientific publications, …

Read more

Is Healthcare Ready for AI?

Artificial Intelligence, or AI, has become the official buzzword of the healthcare industry in recent years, inspiring billions of dollars in investment. When the lives and well-being of patients hang in the balance, do the benefits of using AI outweigh the risks?

Read more